A. N. Alexander

发表

DOSE RESPONSE OF PLASMA ADRENOCORTICOTROPIN AND CORTISOL

W. Vale, J. Rivier, C. Rivier, 1983 .

Effect of synthetic ovine corticotropin-releasing factor: Prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol

W. Vale, J. Rivier, D. Orth, 1984 .

Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor.

W. Vale, J. Rivier, D. Orth, 1984, The Journal of clinical investigation.

Oral IGF-I enhances nutrient and electrolyte absorption in neonatal piglet intestine.

H. V. Carey, A. N. Alexander, H. Carey, 1999, American journal of physiology. Gastrointestinal and liver physiology.

Effect of synthetic ovine corticotropin-releasing factor: prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol.

W. Vale, J. Rivier, D. Orth, 1983, The Journal of clinical endocrinology and metabolism.

Clinical studies with synthetic ovine corticotropin-releasing factor.

J. Rivier, W. Nicholson, D. Orth, 1985, Federation proceedings.

Plasma distribution, disappearance half-time, metabolic clearance rate, and degradation of synthetic ovine corticotropin-releasing factor in man.

W. Vale, J. Rivier, W. Nicholson, 1983, The Journal of clinical endocrinology and metabolism.

Synthetic ovine corticotropin-releasing hormone: simultaneous release of proopiolipomelanocortin peptides in man.

W. Vale, J. Rivier, D. Orth, 1984, The Journal of clinical endocrinology and metabolism.

Insulin-Like Growth Factor-I Stimulates Na+-Dependent Glutamine Absorption in Piglet Enterocytes

A. N. Alexander, H. Carey, 2002, Digestive Diseases and Sciences.

Combined treatment with an LHRH agonist and testosterone in man. Reversible oligozoospermia without impotence.

W. Vale, J. Rivier, A. N. Alexander, 1983, Journal of andrology.

Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma

R. Dubielzig, E. Macewen, D. Vail, 2006, Cancer Immunology, Immunotherapy.

Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor.

W. Vale, J. Rivier, C. Rivier, 1982, The Journal of clinical endocrinology and metabolism.

Clinical and immunohistochemical characterization of thymic lymphosarcoma in a heifer.

P. Constable, R. French, D. Morin, 1996, Journal of veterinary internal medicine.

Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.

W. Vale, J. Rivier, C. Rivier, 1983, The Journal of clinical investigation.

Antifertility effects of an LHRH agonist in men

A. N. Alexander, R. Evans, D. Rabin, 1984 .

Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.

A. N. Alexander, R. Evans, D. Rabin, 1984, The Journal of clinical endocrinology and metabolism.

Heterogeneity of sperm density profiles following 20-week therapy with high-dose LHRH analog plus testosterone.

W. Vale, J. Rivier, G. W. Liddle, 1984, Journal of andrology.

Oral IGF-I enhances nutrient and electrolyte absorption in neonatal piglet intestine.

A. N. Alexander, H. Carey, 1999, The American journal of physiology.

Suppression of plasma testosterone leads to an increase in serum total and high density lipoprotein cholesterol and apoproteins A-I and B.

G. Getz, R. Goldberg, A. N. Alexander, 1985, The Journal of clinical endocrinology and metabolism.

Involvement of PI 3-kinase in IGF-I stimulation of jejunal Na+-K+-ATPase activity and nutrient absorption.

A. N. Alexander, H. Carey, 2001, American journal of physiology. Gastrointestinal and liver physiology.